Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Advisory Services Network LLC

Advisory Services Network LLC cut its position in Hologic, Inc. (NASDAQ:HOLXGet Rating) by 3.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 32,819 shares of the medical equipment provider’s stock after selling 1,322 shares during the period. Advisory Services Network LLC’s holdings in Hologic were worth $2,521,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Hologic by 1.4% in the first quarter. Vanguard Group Inc. now owns 27,882,301 shares of the medical equipment provider’s stock valued at $2,141,919,000 after purchasing an additional 381,608 shares during the period. BlackRock Inc. boosted its holdings in Hologic by 2.5% in the fourth quarter. BlackRock Inc. now owns 21,888,278 shares of the medical equipment provider’s stock valued at $1,675,766,000 after purchasing an additional 532,526 shares during the period. State Street Corp boosted its holdings in Hologic by 0.8% in the first quarter. State Street Corp now owns 11,426,634 shares of the medical equipment provider’s stock valued at $877,794,000 after purchasing an additional 94,561 shares during the period. Geode Capital Management LLC boosted its holdings in Hologic by 7.4% in the fourth quarter. Geode Capital Management LLC now owns 5,790,351 shares of the medical equipment provider’s stock valued at $442,486,000 after purchasing an additional 398,923 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in Hologic by 29.6% in the first quarter. JPMorgan Chase & Co. now owns 3,424,059 shares of the medical equipment provider’s stock valued at $263,039,000 after purchasing an additional 781,084 shares during the period. 85.70% of the stock is owned by institutional investors and hedge funds.

Hologic Stock Down 1.2 %

HOLX opened at $66.82 on Friday. The business’s 50-day simple moving average is $70.09 and its 200-day simple moving average is $72.50. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.32 and a current ratio of 3.91. Hologic, Inc. has a one year low of $66.36 and a one year high of $80.49. The stock has a market capitalization of $16.68 billion, a P/E ratio of 11.27, a price-to-earnings-growth ratio of 0.77 and a beta of 1.05.

Hologic (NASDAQ:HOLXGet Rating) last posted its quarterly earnings data on Wednesday, July 27th. The medical equipment provider reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.26. Hologic had a return on equity of 37.48% and a net margin of 28.93%. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $896.71 million. During the same period last year, the firm earned $1.33 EPS. The firm’s revenue for the quarter was down 14.2% on a year-over-year basis. Analysts anticipate that Hologic, Inc. will post 5.82 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on HOLX shares. Morgan Stanley decreased their price target on Hologic from $72.00 to $70.00 and set an “equal weight” rating for the company in a report on Thursday, July 28th. Bank of America downgraded Hologic from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $81.00 to $75.00 in a report on Wednesday, July 20th. UBS Group started coverage on Hologic in a report on Wednesday, July 20th. They set a “neutral” rating and a $73.00 price target for the company. Finally, BTIG Research downgraded Hologic from a “buy” rating to a “neutral” rating in a report on Monday, July 18th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $76.71.

Hologic Company Profile

(Get Rating)

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.

See Also

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLXGet Rating).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.